Cardiovascular Research Advance Access published August 12, New pathophysiological function of protein phosphatase 2A?
|
|
- Alaina Morrison
- 6 years ago
- Views:
Transcription
1 Cardiovascular Research Advance Access published August 12, EDITORIAL New pathophysiological function of protein phosphatase 2A? Joachim Neumann* Institut für Pharmakologie und Toxikologie, Medizinische Fakultät, Martin- Luther Universität Halle-Wittenberg, Magdeburger Str. 4, Halle Tel: (0) , Fax: (0) , * joachim.neumann@medizin.uni-halle.de See article by Larsen et al. (pages XXX XXX) in this issue. Published on behalf of the European Society of Cardiology. All rights reserved. The Author For permissions please journals.permissions@oxfordjournals.org
2 2 In this issue of the Journal, there is an interesting study by Larsen and coworkers 1. The authors provide evidence that in pulmonary hypoxia a new mechanism might be operational that explains the deterioration of heart function in primary pulmonary hypertension. The authors chronically exposed mice to 10% oxygen in order to mimic hypoxia in patients. The authors had noted in previous studies that this degree of pulmonary hypoxia leads to slower cardiac relaxation, putatively due to reduced phosphorylation of phospholamban on amino acid serine 16. In the present report they provide evidence that the activity of phosphatase 2A but not phosphatase 1 is enhanced in sarcoplasmic reticulum-enriched membranes from these hearts. This led to reduced phosphorylation of phospholamban, which could explain reduced cardiac contractility. Surprisingly, a similar increase in phosphatase activity was noted in left ventricular as well as in right ventricular preparations. Based on the model and the clinical feature of pulmonary hypertension, one would have expected only a right ventricular increase in phosphatase activity. This could indicate that a humoral mechanism, such as altered interleukin levels, increases transcriptional activity of the PP2A gene. The role of serine/threonine phosphatases in the heart has gained considerable attention. For instance, it is well known that increased activity of calcineurin, also known as phosphatase 2B, leads to cardiac hypertrophy. If the animals are treated with an inhibitor on the enzyme (cyclosporine A), this hypertrophy is prevented. Also, if transgenic animals are engineered with additional overexpression of MCIP, a protein inhibitor of calcineurin, this hypertrophy can also be antagonised (for review 2 ). Moreover, there is evidence that increased expression of the catalytic subunit of PP1α occurs in human heart failure 3,4, and mice with overexpression of the catalytic subunit of PP1α also exhibit hypertrophy, fibrosis and increased mortality 5. If the phosphatase activity is reduced by use of an adenovirus, the phenotype of the animals is rescued 5. On the other hand, if the protein inhibitor of PP1, namely I-1, is knocked out, increased PP1 activity and cardiac hypertrophy is noted 5. Similarly, if I-2 of PP1
3 3 is overexpressed, the heart exhibits a hypercontractile state under basal conditions, probably because the phosphorylation state of phospholamban is enhanced 6. Some studies on the cardiac role on PP2A, which occurs as a dimer or trimer (Fig. 1), have also been performed (for review 7 ). For instance, overexpression of a dominant negative mutant of the structural A-subunit of PP2A increases PP2A activity, and this leads to cardiac hypertrophy 8. The function of the regulatory B- subunit has not yet been studied by overexpression in the heart (Fig. 1). Moreover, inhibition of PP2A with a drug, fostriecin, protected rabbit hearts against ischemia 9. If the catalytic subunit of PP2A is overexpressed, this leads to cardiac hypertrophy, impaired cardiac function and decreased phosphorylation of cardiac regulatory proteins like phospholamban and the inhibitory subunit of troponin 10. In addition, in at least some animal models of cardiac hypertrophy, increased activity of PP2A has been observed 11. Thus, it is interesting that PP2A can apparently also be regulated by hypoxia (see Fig. 1). One can speculate that a drug such as fostriecin that is able to decrease PP2A activity might be beneficial in primary pulmonary hypertension. However, this drug is usually used in patients suffering from carcinoma. In fact, fostriecin has other effects besides phosphatase inhibition, including effects on topoisomerases 12. Hence, PP2A might be an interesting target for future pharmaceutical research to design organic compounds that selectively inhibit this enzyme. While it is well established that proteins like I-1 PP2A or I-2 PP2A exist 13, it cannot be predicted whether these would be useful for gene therapy of primary pulmonary hypertension or chronic obstructive pulmonary disease as they are known to increase PP1 activity to some extent 14. In summary, the paper by Larsen et al. opens a new field of research into a pathophysiological role of PP2A.
4 References 4 1. Larsen KO, Lygren B, Sjaastad I, Krobert KA, Arnkværn K, Florholmen G, et al. Diastolic dysfunction in alveolar hypoxia: a role for interleukin-18-mediated increase in protein phosphatase 2A. Cardiovasc Res doi: /cvr/cvn Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7: Neumann J, Eschenhagen T, Jones LR, Linck B, Schmitz W, Scholz H, et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J Mol Cell Cardiol 1997; 29: Mishra S, Gupta RC, Tiwari N, Sharow VG, Sabbah HN. Molecular mechanisms of reduced sarcoplasmic reticulum Ca2+ uptake in human failing left ventricular myocardium. J Heart Lung Transplant 2002; 21: Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 2002; 22: Kirchhefer U, Baba HA, Boknik P, Breeden KM, Mavila N, Brüchert N, et al. Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2. Cardiovasc Res 2005; 68; Janssens V, Longin S, Goris J (2008) PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci 2000; 33: Brewis N, Ohst K, Fields K, Rapacciuolo A, Chou D, Bloor C, et al. Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A. Am J Physiol 2000; 279: H1307 H Weinbrenner C, Baines CP, Liu GS, Armstrong SC, Ganote CE, Walsh AH, et al. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 1998; 98: Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I, et al. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem 2004; 279: Bokník P, Fockenbrock M, Herzig S, Knapp J, Linck B, Lüss H, et al. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: Larsen AK, Escargueil AE, Skladanowski A (2003) Catalytic topoisomerase II inhibitors in cancer therapy. Pharmacol Ther 99: Li M, Makkinje A, Damuni Z. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 1996; 271: Katayose Y, Li M, Al-Murrani SWK, Shenolikar S, Damuni Z. Protein phosphatase 2A inhibitors, I1PP2A and I2PP2A, associate with and modify the substrate specificity of protein phosphatase 1. J Biol Chem 2000; 275:
5 5 Figure Legend: PP2A is composed of three subunits (A, B, C = catalytic subunits). Heart failure and/or hypoxia lead to increased expression of the C subunit and thereby increased phosphatase activity, which results in decreased phosphorylation and hence decreased function of cardiac regulatory proteins. For further details see text. PP2A Fig. 1? hypoxia heart failure?? A C B increased expression decreased phosphorylation of regulatory proteins
Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload
Cardiovascular Research (2008) 79, 464 471 doi:10.1093/cvr/cvn113 Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload Stephanie
More informationIndex. A Action potential duration, increased, by decreases in sodium current,
Heart Failure Clin 1 (2005) 313 319 Index Note: Page numbers of article titles are in boldface type. A Action potential duration, increased, by decreases in sodium current, 201 202 Adenylyl cyclase, overexpression
More informationEffects of sitagliptin on cardiac metabolism in mice
Effects of sitagliptin on cardiac metabolism in mice M. Lenski, J.-C. Reil, M. Böhm, U. Laufs Saarland University Hospital Department of Internal Medicine III, Cardiology Homburg - Germany Disclosures
More informationType 1 Phosphatase, a Negative Regulator of Cardiac Function
MOLECULAR AND CELLULAR BIOLOGY, June 2002, p. 4124 4135 Vol. 22, No. 12 0270-7306/02/$04.00 0 DOI: 10.1128/MCB.22.12.4124 4135.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationReversible protein phosphorylation represents the cellular
Enhancement of Cardiac Function and Suppression of Heart Failure Progression By Inhibition of Protein Phosphatase 1 Anand Pathak,* Federica del Monte,* Wen Zhao, Jo-El Schultz, John N. Lorenz, Ilona Bodi,
More informationDeclaration of conflict of interest. I have nothing to disclose.
Declaration of conflict of interest I have nothing to disclose. Left Bundle branch block in HF: DO GENETICS MATTER? Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University
More informationMyocardial lipid accumulation and lipotoxicity in heart failure
Myocardial lipid accumulation and lipotoxicity in heart failure P. Christian Schulze, MD, PhD New York - Presbyterian Hospital, Columbia University Medical Center, Division of Cardiology, New York, NY,
More informationAltered function in atrium of transgenic mice overexpressing triadin 1
Am J Physiol Heart Circ Physiol 283: H1334 H1343, 2002. First published May 30, 2002; 10.1152/ajpheart.00937.2001. Altered function in atrium of transgenic mice overexpressing triadin 1 UWE KIRCHHEFER,
More informationEarlier studies, mainly in rodents, have shown that diabetic
Downregulation of Myocardial Myocyte Enhancer Factor 2C and Myocyte Enhancer Factor 2C Regulated Gene Expression in Diabetic Patients With Nonischemic Heart Failure Peter Razeghi, MD; Martin E. Young,
More informationProtein kinase A mediated stimulation of activating transcription factor 3 by hypertrophic stimuli in cardiomyocytes
Protein kinase A mediated stimulation of activating transcription factor 3 by hypertrophic stimuli in cardiomyocytes Elina Koivisto, MD, PhD Institute of Biomedicine, Department of Pharmacology and Toxicology
More informationExercise in Adverse Cardiac Remodeling: of Mice and Men
Exercise in Adverse Cardiac Remodeling: of Mice and Men 17-01-2013 Dirk J Duncker Experimental Cardiology, Cardiology, Thoraxcenter Cardiovascular Research Institute COEUR Erasmus MC, University Medical
More informationProf. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.
Obesity as a risk factor for Atrial Fibrillation Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept. CardioAlex 2010 smrafla@hotmail.com 1 Obesity has reached epidemic proportions in the United
More informationCell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction. Rita Alonaizan
Cell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction Rita Alonaizan Department of Physiology, Anatomy & Genetics St Catherine s College Supervisor:
More informationCT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea
CT for Myocardial Characterization of Cardiomyopathy Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea Cardiomyopathy Elliott P et al. Eur Heart J 2008;29:270-276 The European Society
More informationPathophysiology of Coronary Microvascular Dysfunction
Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive
More informationThe ubiquitin proteasome system in cardiovascular disease Basic mechanisms
ECS Congress 2010 Stockholm, Sweden 28 Aug 2010 01 Sep 2010 The ubiquitin proteasome system in cardiovascular disease Basic mechanisms Saskia Schlossarek Department of Experimental and Clinical Pharmacology
More informationEHRA/EUROPACE 2011 Madrid, Spain June
EHRA/EUROPACE 2011 Madrid, Spain June 26.-29.2011 Implementing modern management in atrial fibrillation patients Proceedings from the 3rd AFNet/EHRA consensus conference EHRA Special Session Different
More informationUNIVERSITY OF CINCINNATI
UNIVERSITY OF CINCINNATI Date: I,, hereby submit this work as part of the requirements for the degree of: in: It is entitled: This work and its defense approved by: Chair: Protein Kinase Cα & p38 Protein
More informationTKIs ( Tyrosine Kinase Inhibitors ) Mechanism of action and toxicity in CML Patients. Moustafa Sameer Hematology Medical Advsior,Novartis oncology
TKIs ( Tyrosine Kinase Inhibitors ) Mechanism of action and toxicity in CML Patients Moustafa Sameer Hematology Medical Advsior,Novartis oncology Introduction In people with chronic myeloid leukemia, A
More informationA NEW RISK FACTOR FOR EARLY HEART FAILURE: PRETERM BIRTH
A NEW RISK FACTOR FOR EARLY HEART FAILURE: PRETERM BIRTH 1* Paul Leeson, PhD, FRCP and 1 Adam J. Lewandowski, DPhil 1 Oxford Cardiovascular Clinical Research Facility, Division of Cardiovascular Medicine,
More informationHFPEF Echo with Strain vs. MRI T1 Mapping
HFPEF Echo with Strain vs. MRI T1 Mapping Erik Schelbert, MD MS Director, Cardiovascular Magnetic Resonance Assistant Professor of Medicine Heart & Vascular Institute University of Pittsburgh Disclosures
More informationPerioperative Management of TAPVC
Perioperative Management of TAPVC Professor Andrew Wolf Rush University Medical Center,Chicago USA Bristol Royal Children s Hospital UK I have no financial disclosures relevant to this presentation TAPVC
More informationRevision. camp pathway
االله الرحمن الرحيم بسم Revision camp pathway camp pathway Revision camp pathway Adenylate cyclase Adenylate Cyclase enzyme Adenylate cyclase catalyses the formation of camp from ATP. Stimulation or inhibition
More informationMathematical Model of the Electromechanical Heart Contractile System Regulatory Subsystem Physiological Considerations
Physiol. Res. 50: 425-432, 2001 Mathematical Model of the Electromechanical Heart Contractile System Regulatory Subsystem Physiological Considerations M. MLČEK, J. NEUMANN, O. KITTNAR, V. NOVÁK Institute
More informationPhysiology sheet #2. The heart composed of 3 layers that line its lumen and cover it from out side, these layers are :
Physiology sheet #2 * We will talk in this lecture about cardiac muscle physiology, the mechanism and the energy sources of their contraction and intracellular calcium homeostasis. # Slide 4 : The heart
More informationNFκB What is it and What s the deal with radicals?
The Virtual Free Radical School NFκB What is it and What s the deal with radicals? Emily Ho, Ph.D Linus Pauling Institute Scientist Department of Nutrition and Food Management Oregon State University 117
More informationSerotonin in the heart: the beauty and the beast
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse CH-0 Zurich www.zora.uzh.ch Year: Bogdanova, A DOI: https://doi.org/0./j.-..0.x Posted at the Zurich Open Repository
More informationCOMPUTATIONAL MODELING AND NANOTECHNOLOGY FOR INVESTIGATING AND IMPROVING CARDIAC CELL FUNCTION
COMPUTATIONAL MODELING AND NANOTECHNOLOGY FOR INVESTIGATING AND IMPROVING CARDIAC CELL FUNCTION L. T Al-Kury Faculty of Pharmacy and Health Science, Ajman University, P.O.Box 5102, Abu-Dhabi, U.A.E I.
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationMyocardial Infarction
Myocardial Infarction MI = heart attack Defined as necrosis of heart muscle resulting from ischemia. A very significant cause of death worldwide. of these deaths, 33% -50% die before they can reach the
More informationCovalent and Noncovalent Modification of Thin Filament Action: The Essential Role of Troponin in Cardiac Muscle Regulation
This Review is part of a thematic series on Regulatory Signaling by Thin Filament Modulation, which includes the following articles: Modulation of Thin Filament Activation by Breakdown or Isoform Switching
More informationRemodeling the failing heart: : the biology and future treatment options
Remodeling the failing heart: : the biology and future treatment options J-L Balligand (UCL-Brussels, BE) jl.balligand@uclouvain.be Myocardial remodeling: definitions phenotypic plasticity : remodeling
More informationPOSTDOCTORAL TRAINING
2 Curriculum Vitae JULIAN E. STELZER, PhD CONTACT DETAILS Phone: 216-368-8636 julian.stelzer@case.edu EDUCATION 1992-96 McGill University, Montréal, Canada BS, Physiology. 1996-98 University of Saskatchewan,
More informationArrhythmias. Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium.
Arrhythmias Simple-dysfunction cause abnormalities in impulse formation and conduction in the myocardium. However, in clinic it present as a complex family of disorders that show variety of symptoms, for
More informationExtracellular matrix Basic and translational science: Highlights of the congress
Extracellular matrix Basic and translational science: Highlights of the congress Stephane Heymans, Maastricht University Medical Centre, CARIM, Netherlands Speaker The extracellular matrix modulates cardiac
More informationBIOMEDICAL SCIENCES GRADUATE PROGRAM SPRING 2018
THE OHIO STATE UNIVERSITY BIOMEDICAL SCIENCES GRADUATE PROGRAM SPRING 2018 Jae-Hoon Chung PhD Candidate Regulation of Human Cardiac Muscle Contraction and Relaxation in Health and Disease February 26,
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationOriginal Article Ca 2+ -calcineurin signaling is involved in norepinephrine-induced cardiac fibroblasts activation
Int J Clin Exp Pathol 2015;8(5):5210-5216 www.ijcep.com /ISSN:1936-2625/IJCEP0007997 Original Article Ca 2+ -calcineurin signaling is involved in norepinephrine-induced cardiac fibroblasts activation Chun-Jing
More informationVets 111/Biov 111 Cell Signalling-2. Secondary messengers the cyclic AMP intracellular signalling system
Vets 111/Biov 111 Cell Signalling-2 Secondary messengers the cyclic AMP intracellular signalling system The classical secondary messenger model of intracellular signalling A cell surface receptor binds
More informationAge-related changes in cardiovascular system. Dr. Rehab Gwada
Age-related changes in cardiovascular system Dr. Rehab Gwada Objectives explain the main structural and functional changes in cardiovascular system associated with normal aging Introduction aging results
More informationBIOCHEMICAL EXAMINATION OF ACUTE MYOCARDIAL INFARCTION. Written by Lenka Fialová, translated by Jan Pláteník
BIOCHEMICAL EXAMINATION OF ACUTE MYOCARDIAL INFARCTION 1 Structure of heart muscle Written by Lenka Fialová, translated by Jan Pláteník Heart muscle (myocardium) is a particular form of striated muscle,
More informationNew drugs on the horizon for heart failure: CaMK antagonists
New drugs on the horizon for heart failure: CaMK antagonists (Lars S. Maier) Gerd Hasenfuss Disclosure Information: No relationship exists related to this presentation Dept. of Cardiology and Pneumology,
More informationJournal of the American College of Cardiology Vol. 34, No. 2, by the American College of Cardiology ISSN /99/$20.
Journal of the American College of Cardiology Vol. 34, No. 2, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00220-X REVIEW
More informationRotation: Echocardiography: Transthoracic Echocardiography (TTE)
Rotation: Echocardiography: Transthoracic Echocardiography (TTE) Rotation Format and Responsibilities: Fellows rotate in the echocardiography laboratory in each clinical year. Rotations during the first
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More informationHypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy From Genetics to ECHO Alexandra A Frogoudaki Second Cardiology Department ATTIKON University Hospital Athens University Athens, Greece EUROECHO 2010, Copenhagen, 11/12/2010
More informationIndex of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125
145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency
More information1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and
1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,
More informationTo Correlate Ejection Fraction with 6 Minute Walked Distance and Quality of Life in Patients with Left Ventricular Heart Failure
To Correlate Ejection Fraction with 6 Minute Walked Distance and Quality of Life in Patients with Left Ventricular Heart Failure Pramila S Kudtarkar*, Mariya P Jiandani*, Ashish Nabar** Abstract Purpose
More informationJ Jpn Coll Angiol, 2009, 49:
Online publication October 6, 2009 48 2 20 J Jpn Coll Angiol, 2009, 49: 293 297 atrial natriuretic peptide, brain natriuretic peptide, guanylyl cyclase-a receptor, cardiac remodeling, cardiac hypertrophy
More informationChapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure
Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for
More informationManaging Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology
Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation
More informationRT-100 technical summary (as of March 2015) Table of contents
RT-100 technical summary (as of March 2015) Table of contents 1. Major unmet clinical need 2. Gene therapy 3. Adenylyl cyclase and heart failure 4. Clinical congestive heart failure 5. lntracoronary adenovirus
More informationCardiac Sarcoidosis. Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar
Cardiac Sarcoidosis Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar Introduction Multisystem granulomatous disease of unknown etiology characterized by noncaseating granulomas in
More informationSecond Generation of Calcium Antagonists
Winifred G. Nayler Second Generation of Calcium Antagonists With 81 Figures and 63 Tables Springer-Verlag Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest Contents Foreword Chapter
More informationLecture 15. Signal Transduction Pathways - Introduction
Lecture 15 Signal Transduction Pathways - Introduction So far.. Regulation of mrna synthesis Regulation of rrna synthesis Regulation of trna & 5S rrna synthesis Regulation of gene expression by signals
More informationG protein-coupled Signal Transduction
Theresa Filtz, hd har 735, Winter 2006 G protein-coupled Signal Transduction Main Objectives (the big chunks) Describe in molecular detail the cascades of events in a generalized G protein-coupled signaling
More informationSupplemental Material. Methods
1 Supplemental Material Methods Functional Characterization of Isolated Cardiomyocytes (Detailed Methods) Left ventricular myocytes were isolated from adult mice (aged 30-38 weeks) by enzymatic dissociation.
More informationThe dynamic regulation of blood vessel caliber
INVITED BASIC SCIENCE REVIEW The dynamic regulation of blood vessel caliber Colleen M. Brophy, MD, Augusta, Ga BACKGROUND The flow of blood to organs is regulated by changes in the diameter of the blood
More informationClinical benefits of trimetazidine in diabetic patients with coronary artery disease
Clinical benefits of trimetazidine in diabetic patients with coronary artery disease Department of Cardiology, Ain Shams University, Cairo, Egypt Correspondence:, Department of Cardiology, Ain Shams University,
More informationGenetic Engineering and Therapy for Inherited and Acquired Cardiomyopathies
Genetic Engineering and Therapy for Inherited and Acquired Cardiomyopathies SHARLENE DAY, a JENNIFER DAVIS, b MARGARET WESTFALL, b,c AND JOSEPH METZGER c a Department of Internal Medicine, University of
More informationMcHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload
McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload Cardiac output (CO) represents the volume of blood that is delivered
More informationEffect of Short-term Maximal Exercise on BNP Plasma Levels in. Healthy Individuals
1 Effect of Short-term Maximal Exercise on BNP Plasma Levels in Healthy Individuals Jan Krupicka, MD, Tomas Janota, MD, Zdislava Kasalova, MD, Jaromir Hradec, MD 3rd Department of Internal Medicine, 1st
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature19102 Supplementary Discussion Benzothiazepine Binding in Ca V Ab Diltiazem and other benzothiazepines inhibit Ca V 1.2 channels in a frequency-dependent manner consistent with pore block
More informationThe cyclic GMP (cgmp) signaling pathway is a ubiquitous
Advances in Heart Failure Protein Kinase G I and Heart Failure Shifting Focus From Vascular Unloading to Direct Myocardial Antiremodeling Effects Qingwu Kong, MS; Robert M. Blanton, MA, MD The cyclic GMP
More informationThe Effects of Decreased Cardiac CapZ Protein on the Myocardial Response to Stress
The Effects of Decreased Cardiac CapZ Protein on the Myocardial Response to Stress by Feng Hua Yang A Thesis presented to The University of Guelph In partial fulfilment of requirements for the degree of
More informationTIGAR's promiscuity Bolaños, Juan P.
TIGAR's promiscuity Bolaños, Juan P. TIGAR [TP53 (tumour protein 53)-induced glycolysis and apoptosis regulator] is an important survival factor for cancer cells. The enzymatic activity supported by sequence
More informationCardiotoxicity from Chemotherapy : From Early Predictors to Therapeutics
Cardiotoxicity from Chemotherapy : From Early Predictors to Therapeutics Richard Sheppard MD FRCPC Director of Heart Failure Research Heart Function Clinic Jewish General hospital Objectives 1. Discuss
More informationChemotherapy- Associated Heart Failure. M. Birhan Yılmaz M.D, FESC Professor of Medicine Department of Cardiology Cumhuriyet University Sivas, TURKEY
Chemotherapy- Associated Heart Failure M. Birhan Yılmaz M.D, FESC Professor of Medicine Department of Cardiology Cumhuriyet University Sivas, TURKEY In last 20 years life-expectancy for patients with cancer
More informationEvidence for protein phosphatase inhibitor-1 playing an amplifier role in β-adrenergic signaling in cardiac myocytes
The FASEB Journal express article 10.1096/fj.02-0057fje. Published online January 2, 2003. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in β-adrenergic signaling in cardiac myocytes
More informationData Alert #2... Bi o l o g y Work i n g Gro u p. Subject: HOPE: New validation for the importance of tissue ACE inhibition
Vascular Bi o l o g y Work i n g Gro u p c/o Medical Education Consultants, In c. 25 Sy l van Road South, We s t p o rt, CT 06880 Chairman: Carl J. Pepine, MD Professor and Chief Division of Cardiovascular
More informationLecture: CHAPTER 13 Signal Transduction Pathways
Lecture: 10 17 2016 CHAPTER 13 Signal Transduction Pathways Chapter 13 Outline Signal transduction cascades have many components in common: 1. Release of a primary message as a response to a physiological
More informationCorrelations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning
Correlations among copeptin, ischemia-modified albumin, and the extent of myocardial injury in patients with acute carbon monoxide poisoning J. Li, J.S. Wang, Z.X. Xie, W.Z. Wang, L. Wang, G.Y. Ma, Y.Q.
More informationDIASTOLIC HEART FAILURE
DIASTOLIC HEART FAILURE M Mohsen Ibrahim, MD Alexandria, Proposed Criteria for Diastolic Heart Failure ESC Working Group (EHJ 1998) CHF signs/symptoms EF 45% Hemodynamic or echo evidence of diastolic dysfunction
More informationHYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen
HYPERTROPHY: Behind the curtain V. Yotova St. Radboud Medical University Center, Nijmegen Disclosure of interest: none Relative wall thickness (cm) M 0.22 0.42 0.43 0.47 0.48 0.52 0.53 F 0.24 0.42 0.43
More informationAperTO - Archivio Istituzionale Open Access dell'università di Torino
AperTO - Archivio Istituzionale Open Access dell'università di Torino From the nucleus to the mitochondria and backthe odyssey of a multitask STAT3 This is the author's manuscript Original Citation: From
More informationAlfonso López. Cardiac Hypertrophy and Dilation
Cardiac Hypertrophy and Dilation Alfonso López Professor of Anatomic Pathology Dept. Pathology and Microbiology Atlantic Veterinary College University of Prince Edward Island Canada Jan 23, 2012 Compensatory
More informationA MODEL OF GAP JUNCTION CONDUCTANCE AND VENTRICULAR TACHYARRHYTHMIA
A MODEL OF GAP JUNCTION CONDUCTANCE AND VENTRICULAR TACHYARRHYTHMIA X. D. Wu, Y. L. Shen, J. L. Bao, C. M. Cao, W. H. Xu, Q. Xia Department of Physiology, Zhejiang University School of Medicine, Hangzhou,
More informationBETA-BLOCKADE AND MYOCARDIAL GENE EXPRESSION MYOCARDIAL GENE EXPRESSION IN DILATED CARDIOMYOPATHY TREATED WITH BETA-BLOCKING AGENTS.
MYOCARDIAL GENE EXPRESSION IN DILATED CARDIOMYOPATHY TREATED WITH BETA-BLOCKING AGENTS BRIAN D. LOWES, M.D., EDWARD M. GILBERT, M.D., WILLIAM T. ABRAHAM, M.D., WAYNE A. MINOBE, B.S., PATTI LARRABEE, B.S.,
More informationSignal Transduction: G-Protein Coupled Receptors
Signal Transduction: G-Protein Coupled Receptors Federle, M. (2017). Lectures 4-5: Signal Transduction parts 1&2: nuclear receptors and GPCRs. Lecture presented at PHAR 423 Lecture in UIC College of Pharmacy,
More informationChronic heart failure is one of the leading causes of
Feedback Inhibition of Catecholamine Release by Two Different 2 -Adrenoceptor Subtypes Prevents Progression of Heart Failure Marc Brede, MD; Frank Wiesmann, MD; Roland Jahns, MD; Kerstin Hadamek; Carsten
More informationGinkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury
Ginkgo biloba extract postconditioning reduces myocardial ischemia reperfusion injury K. Ran 1, D.-L. Yang 1, Y.-T. Chang 1, K.-M. Duan 2, Y.-W. Ou 2, H.-P. Wang 3 and Z.-J. Li 1 1 Department of Anesthesiology,
More informationAcute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema
Acute impairment of basal left ventricular rotation but not twist and untwist are involved in the pathogenesis of acute hypertensive pulmonary oedema A.D. Margulescu 1,2, R.C. Sisu 1,2, M. Florescu 2,
More informationValue of echocardiography in chronic dyspnea
Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting
More informationDiastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure
Diastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure Dr. Shelley Zieroth FRCPC Assistant Professor, Cardiology, University of Manitoba Director of Cardiac Transplant and Heart Failure Clinics
More informationProceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009
www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers MANAGEMENT
More informationDilated cardiomyopathy (DCM) represents a common
Alterations in Janus Kinase (JAK)-Signal Transducers and Activators of Transcription (STAT) Signaling in Patients With End-Stage Dilated Cardiomyopathy Edith K. Podewski, MD; Denise Hilfiker-Kleiner, PhD;
More informationHeart Failure (HF) Treatment
Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and
More informationWolff-Parkinson-White Syndrome and PRKAG2
Wolff-Parkinson-White Syndrome and PRKAG2 Maggie Beatka University of Wisconsin-Madison http://www.beatmap.net/portfolio-detail/human-cardiovascular-system-3drenderings/ What causes Wolff-Parkinson-White?
More informationProtein kinases are enzymes that add a phosphate group to proteins according to the. ATP + protein OH > Protein OPO 3 + ADP
Protein kinase Protein kinases are enzymes that add a phosphate group to proteins according to the following equation: 2 ATP + protein OH > Protein OPO 3 + ADP ATP represents adenosine trisphosphate, ADP
More informationCardiomyopathy Consequences. function of the myocardium for any reason. This is a serious disease in which the heart muscle
Becki Simmons Cardiomyopathy Consequences Cardiomyopathy, which literally means "heart muscle disease," is the deterioration of the function of the myocardium for any reason. This is a serious disease
More informationBiol220 Cell Signalling Cyclic AMP the classical secondary messenger
Biol220 Cell Signalling Cyclic AMP the classical secondary messenger The classical secondary messenger model of intracellular signalling A cell surface receptor binds the signal molecule (the primary
More informationContribution to the Problems of Volume Parameters of the Left Heart Ventricle of Patients with Ischaemic Heart Disease
Physiol. Res. 41:237-241, 1992 Contribution to the Problems of Volume Parameters of the Left Heart Ventricle of Patients with Ischaemic Heart Disease A. VOSEČKOVÁ, H. WEISBAUEROVÁ, J. ŠÍSTEK1 Department
More informationCellular and Molecular Alterations in the Failing Human Heart
Cellular and Molecular Alterations in the Failing Human Heart G. Hasenfuss, Ch. Holubarsch, H. Just, N. R. Alpert (Eds.) Cellular and Molecular Alterations in the Failing Human Heart SteinkopffVerlag Darmstadt.i
More informationAdenylyl cyclase (AC) is the effector molecule in
Adenylyl Cyclase Increases Survival in Cardiomyopathy David M. Roth, PhD, MD; Hamed Bayat, MD; Jeffrey D. Drumm, BS; Mei Hua Gao, PhD; James S. Swaney, MS; Aziz Ander, BS; H. Kirk Hammond, MD Background
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationChanges in myocardial excitation-contraction coupling are
Excessive Sarcoplasmic/Endoplasmic Reticulum Ca 2 -ATPase Expression Causes Increased Sarcoplasmic Reticulum Ca 2 Uptake but Decreases Myocyte Shortening Nils Teucher; Juergen Prestle, PhD; Tim Seidler,
More information